Transcend announced the immediate availability of Transcend 365 miniCPAP, a CPAP and integrated heated humidifier capable of running on a single, travel-size battery.

Transcend introduces patented Capillary Force Vaporizer Technology (CFV) as an alternative to pass-over heated humidification. Unlike traditional CPAP humidifiers that must heat water in a reservoir to humidify a constant airflow, the new Transcend 365 humidifier instantly vaporizes water using an internal element and delivers humidification to the patient during inhalation, “resting” during exhalation. This preserves water and power and provides humidified air from the first breath. The responsive inspiratory-only humidifier also eliminates “rainout,” which describes when condensation collects in the CPAP mask and hose.

Clarence Johnson, Somnetics CEO, says in a release, “This technology is unlike anything seen in CPAPs before. It will be a game changer for sleep apnea patients with active lives and who have been unable to rely on their CPAP and humidifier in travel situations when mains power is not available or during power outages. The small size, complete feature set, and compatibility with any CPAP mask and hose makes the Transcend

ProSomnus Sleep Technologies launches a new oral appliance for obstructive sleep apnea: the ProSomnus [CA] LP continuous advancement sleep apnea device. ProSomnus [CA] LP is a low-profile continuous advancement oral appliance that includes standard ProSomnus appliance features including biocompatible hygienic material, impression-free digital replacements, and device customizations. This new device utilizes proprietary technologies to resolve archform asymmetries, manufacturing variances, bulkiness, and other device design limitations of traditional dorsal style continuous advancement devices, according to the manufacturer.

“We love the precision fit of the ProSomnus [CA] LP, which means less time fussing during delivery,” say Jeffrey S. Rein, DDS and Neal Seltzer, DMD of Long Island Dental Sleep Medicine, in a release. “The small profile is comfortable for patients and allows less protrusion for an effective, therapeutic benefit for this lifetime therapy.”

The FDA cleared device has 34% overall lower profile compared to similar style devices by a competitor (data on file at ProSomnus) and ensures more flex for easy delivery. With natural anatomical scalloping, the ProSomnus [CA] LP is optimized for greater tongue space, measuring 38% less bulk for lip

Cash only medical distributor CPAP EquipSource has opened a sleep apnea retail store and showroom at 6629 Engle Road, Midddleburg Heights, Ohio.

It provides customers with a diagnosis of obstructive sleep apnea (OSA) and who are currently on CPAP therapy with an in-store option to view and purchase the latest masks and machines available, along with accessories such as CPAP cleaning devices.

More controversially, CPAP EquipSource is selling home sleep testing kits (HST) for self-testing and screening of sleep apnea (OSA), which it says in a release “requires neither a prescription nor a visit to the doctor.”

It also offers sleep testing services to institutional providers, including skilled and assisted living facilities.

“Many CPAP patients are frustrated and tired of dealing with their current provider due to lack of service and supply options. This scarcity of parts or service results in patients not being able to use their CPAP devices as prescribed, which can ultimately lead to other, more serious health complications. We offer customers the convenience of being able to pick up a device from our store, if

By Mark Kreidler, California Healthline

AUBURN, Calif. ― Fern Brown, 81, sat in the rear of a tent on the windswept fairgrounds of this historic Gold Rush town, drawing deep breaths through the mouthpiece of a nebulizer plugged into a power strip atop a plastic folding table.

Afflicted for years with asthma and chronic obstructive pulmonary disease, Brown uses the nebulizer twice a day to avoid flare-ups that can be life-threatening. It turns her medicine into a fine mist that she can inhale.

Her machine runs on electricity, and when Pacific Gas & Electric Co. cuts power in the region amid wildfire scares, as it did earlier this week, Brown must scramble to find a place where she can administer her treatment.

She knows the makeshift “resource center” she visited on Tuesday afternoon, one of several set up this week by PG&E, is not a viable long-term fix ― especially now that power outages and the uncertainty that comes with them seem likely to be a more frequent feature of California’s fire season.

“I could rent a generator. Or can

Conventional wisdom describes insomnia as a mental problem best treated with sleeping pills. Though research has hinted at a physical connection between obstructive sleep apnea (OSA) and chronic insomnia (sometimes referred to as “complex insomnia”), no one had accurately measured how often OSA caused insomnia in a representative sample or tested how to optimize therapy.

But now a new study provides surprising insights into the prevalence and treatment of complex insomnia. Published in The Lancet’s EClinicalMedicine and funded by the ResMed Science Center, the findings show that a whopping 80% of treatment-seeking people with insomnia are experiencing physiological fragmentation of their sleep and resultant chronic insomnia from undiagnosed OSA. And the therapy that worked for most? Adaptive servoventilation (ASV).

Study Setup

Patients interested in a “chronic insomnia research study” were assessed by the researchers to see if they indeed had the markers for a chronic insomnia disorder diagnosis. Of the 1,663 who expressed interest, 1,003 were excluded up front due to not having all the symptoms required for the diagnosis (including 744 who did not experience impairment due to their

A research team led by the University of Minnesota (U of M) Morris found that a trucking firm that mandated treatment for its drivers with obstructive sleep apnea (OSA) saved significantly on non-OSA-program medical insurance costs.

In new research published in the medical journal Sleep, the U of M Morris-led research team addressed this concern by identifying the savings on the costs of other medical conditions that result from treating OSA.

Researchers analyzed the medical insurance claims of drivers enrolled in the study firm’s sleep apnea screening, diagnosis, and treatment program. To estimate the savings in claims for an individual driver receiving treatment, the research team used a multivariate model to compare the costs of drivers accepting treatment and those refusing it. After excluding claims related to the program itself, they found a savings of $441 per driver per month for the typical driver who accepted treatment.

To estimate the aggregate savings for 100 drivers who were diagnosed and treated, the researchers compared them to 100 “screen-positive” controls (drivers screened as likely to have OSA who had not yet